EverSource Wealth Advisors’s ADMA Biologics ADMA Stock Holding History

EverSource Wealth Advisors’s Portfolio ADMA Stock Details ADMA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$8.37K	Sell	1,000 -6,559	-87%	-$59.8K	﹤0.01%	3006
2026 Q1	$68.1K	Buy	7,559 +1,162	+18%	+$18.3K	﹤0.01%	1670
2025 Q4	$117K	Buy	6,397 +3,925	+159%	+$66.2K	﹤0.01%	1235
2025 Q3	$36.2K	Sell	2,472 -273	-10%	-$4.68K	﹤0.01%	1938
2025 Q2	$50K	Buy	2,745 +2,180	+386%	+$44.5K	﹤0.01%	1618
2025 Q1	$11.2K	Buy	565 +89	+19%	+$1.54K	﹤0.01%	2048
2024 Q4	$8.16K	Buy	476 +255	+115%	+$4.8K	﹤0.01%	2105
2024 Q3	$4.42K	Buy	221 +85	+63%	+$1.32K	﹤0.01%	2273
2024 Q2	$1.67K	Buy	+136	New	+$1.14K	﹤0.01%	2608

Other funds holding ADMA

AAP

Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return

YIH

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

MCM

Marathon Capital Management Hunt Valley, Maryland $494M AUM 42.6% 1-Year Est. Return

PFG Investments Woodbury, New York $2.58B AUM 36.93% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

SOADOR

State of Alaska Department of Revenue Juneau, Alaska $10.1B AUM 42.83% 1-Year Est. Return

LSERS

Louisiana State Employees Retirement System Baton Rouge, Louisiana $6.74B AUM 53.06% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

MFG

Merit Financial Group Alpharetta, Georgia $16.4B AUM 25.17% 1-Year Est. Return

PFSRSONJ

Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

EverSource Wealth Advisors's ADMA Position: Q2 2026 in Review

EverSource Wealth Advisors reduced its ADMA Biologics (ADMA) stake by 87% in Q2 2026, selling an estimated $59.8K and leaving 1,000 shares worth $8.37K. The position accounts for ﹤0.01% of the portfolio, ranked #3006.

EverSource Wealth Advisors first reported a position in ADMA in Q2 2024 and has held it in 9 quarters since. The position peaked at $117K in Q4 2025. 62 funds tracked by Wall St. Rank hold ADMA as of Q2 2026.

EverSource Wealth Advisors held 1,000 shares of ADMA Biologics worth $8.37K as of Q2 2026.
EverSource Wealth Advisors sold 6,559 ADMA Biologics shares in Q2 2026, an estimated $59.8K.
ADMA Biologics made up ﹤0.01% of EverSource Wealth Advisors's portfolio in Q2 2026, its #3006 holding.
EverSource Wealth Advisors first reported a position in ADMA Biologics in Q2 2024 and has held it in 9 quarters since.
EverSource Wealth Advisors's ADMA Biologics position peaked at $117K in Q4 2025.
62 funds tracked by Wall St. Rank held ADMA Biologics as of Q2 2026.

Based on EverSource Wealth Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.